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Abstract Bone formation is precisely regulated by cell-cell
communication in osteoblasts. We have previously demon-
strated that genetic deletion of Col6a1 or Col12a1 impairs
osteoblast connections and/or communication in mice,
resulting in bone mass reduction and bone fragility.
Mutations of the genes encoding collagen VI cause Ullrich
congenital muscular dystrophy (UCMD) and Bethlem myop-
athy (BM), which have overlapping phenotypes involving
connective tissue and muscle. Recent studies have identified
COL12A1 gene mutations in patients with UCMD- and BM-
like disorders harboring no COL6 mutations, indicating the
shared functions of these collagens in connective tissue ho-
meostasis. The purpose of this investigation has been to test
the hypothesis that collagens VI and XII have coordinate reg-
ulatory role(s) during bone formation. We analyzed the local-
ization of collagens VI and XII relative to primary osteoblasts
during osteogenesis. Immunofluorescence analysis demon-
strated that collagens VI and XII colocalized in matrix bridges
between adjacent cells during periods when osteoblasts were
establishing cell-cell connections. Quantification of cells har-
boring collagen bridges demonstrated that matrix bridges
were composed of collagens VI and XII but not collagen I.
Interestingly, matrix bridge formation was impaired in osteo-
blasts deficient in either Col6a1 or Col12a1, suggesting that
both collagens were indispensable for matrix bridge forma-
tion. These data demonstrate, for the first time, a functional
relationship between collagens VI and XII during osteogene-
sis and indicate that a complex containing collagens VI and
XII is essential for the formation of a communicating cellular
network during bone formation.
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Introduction
Bone formation is precisely regulated by cell-cell communi-
cation in osteoblasts at bone-forming sites. During bone for-
mation, pre-osteoblasts migrate toward the bone-forming sites
where osteoblasts establish connections with adjacent osteo-
blasts, thereby forming a communicating cell network. This
network allows osteoblasts to form appropriate amounts of
high-quality bone. However, the mechanisms regulating this
communicating cell network are still not clear.
Cells are surrounded by extracellular matrix in vivo; this
matrix provides the proper environment for cells and varies
depending on specific cellular events. We have previously
demonstrated that collagens VI and XII are localized at
bone-forming sites and that genetic deletion of Col6a1 or
Col12a1 causes impaired osteoblast arrangement, resulting
in decreased bone mass and strength (Izu et al. 2011b,
2012). In addition, osteoblast cellular events, such as
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polarization, which is required for osteoblast terminal matura-
tion, bone matrix secretion, and cell-cell connection/
communication via gap junctions, are impaired in Col12a1-
deficient mice (Izu et al. 2011b). These data suggest that col-
lagens VI and XII mediate cell communication during bone
formation. However, the possible coordinated role(s) of colla-
gens VI and XII in the regulation of osteoblast cell communi-
cation at bone-forming sites have not been defined.
Mutations in genes encoding collagen VI (i.e., COL6A1,
COL6A2, and COL6A3) have been identified as causative in
Ullrich congenital muscular dystrophy (UCMD) and Bethlem
myopathy (BM). These diseases have overlapping phenotypes
involving connective tissue and skeletal muscle. Both are ear-
ly onset diseases, patients with UCMD have severe muscle
weakness and distal joint hyperlaxity with proximal joint con-
tractures, whereas in BM there is a relatively mild proximal
weakness and distal joint contractures. However, not all pa-
tients with a clinical diagnosis of UCMD or BM have muta-
tions in COL6 genes. Recently, COL12A1 gene mutations
have been identified in patients with UCMD-like (Zou et al.
2014) and BM-like disorders (Hicks et al. 2014) without
COL6 mutations. Moreover, collagen XII deficiency has also
been shown to contribute to UCMD- and BM-like pheno-
types, as demonstrated by genetic deletion of Col12a1 in
mice, which results in muscular dystrophy, decreased grip
strength (Zou et al. 2014), and connective tissue defects, such
as kyphosis and decreased bone mass (Izu et al. 2011b). This
supports the hypothesis that there is a mechanism(s) involving
coordinated collagen VI and XII interactions in muscle and
connective tissue development.
Collagen VI is a non-fibrillar collagen, forms characteristic
microfibrillar networks, and is ubiquitously localized in con-
nective tissues, including bone. The assembly of collagen VI
is a multistep process; a short triple helical monomer
consisting of α1(VI), α2(VI), and α3(VI) is formed and sub-
sequently assembles into disulfide bonded antiparallel dimers.
The dimers further assemble into tetramers (Allamand et al.
2011; Baldock et al. 2003; Ball et al. 2003; Engel et al. 1985;
Engvall et al. 1986; Mienaltowski and Birk. 2014). Collagen
VI is secreted as a tetramer, which forms microfibril networks
in the extracellular milieu. Collagen XII is also a non-fibrillar
collagen and is widely expressed in connective tissues, includ-
ing bone, ligaments, tendons, fibrocartilage, smooth muscle,
skin (Walchli et al. 1994), articular cartilage (Watt et al. 1992),
and cornea (Anderson et al. 2000; Hemmavanh et al. 2013). In
contrast to collagen VI, collagen XII belongs to the family of
fibril-associated collagens with interrupted triple helices
(FACIT; Chiquet et al. 2014; Dublet et al. 1989; Gordon
et al. 1987; Oh et al. 1992) and consists of a homotrimer of
α1(XII) chains at the C-terminus with three non-collagenous
domains and a large globular N-terminal domain. Therefore,
these collagens are structurally distinct; however, mutations in
both collagen genes cause common diseases.
Collagen VI interacts with a wide variety of proteins via its
globular domain, which contains numerous different binding
sites (Chen et al. 2015; Doane et al. 1998; Howell and Doane.
1998). On the other hand, collagen XII interacts with collagen
I via the collagenous domain (Font et al. 1996; Keene et al.
1991; Koch et al. 1995; Nishiyama et al. 1994), and a large N-
terminal globular domain, NC3, provides a possible interac-
tion with other molecules such as tenascin X (Veit et al. 2006),
decorin, and fibromodulin (Font et al. 1996, 1998; Massoudi
et al. 2012). Therefore, both collagens have the ability to me-
diate cell-matrix and matrix-matrix interactions, which are
important features regulating cell migration, adhesion, apo-
ptosis, and survival. Based on these shared functions, there
may be a common regulatory system mediated by collagens
VI and XII.
Here, we demonstrate that collagens VI and XII are spa-
tially co-localized during osteoblast development in primary
osteoblasts derived from neonatal mouse calvaria. This
colocalization is restricted to matrix bridges that lie between
adjacent cells and that are formed when osteoblasts make cell-
cell connections. Since collagen I is virtually absent from ma-
trix bridges and collagens VI and XII are indispensible for
matrix bridge formation, we propose the existence of a colla-
gen VI/XII complex that has a novel regulatory role(s) in
mediating cell-cell interactions during communicating cell
network formation at bone-forming sites.
Materials and methods
Cell culture
Primary osteoblasts were obtained from calvaria of wild-type,
Col6a1−/−, or Col12a1−/− neonatal mice by using sequential
enzyme digestion, as previously described (Izu et al. 2011b).
Primary osteoblasts were maintained in α-minimal essential
medium supplemented with 10 % fetal bovine serum (FBS)
and antibiotics (Life Technologies, Rockville, Md., USA) as a
non-osteogenic medium. Non-osteogenic medium supple-
mented with phospho-ascorbic acid (100 μg/ml) and β-
glycerophosphate (10 mM) was used as osteogenic medium
to induce osteogenesis in primary osteoblasts that were previ-
ously maintained in non-osteogenic medium.
Immmunolocalization analysis
Immunofluorescence analysis was performed in primary oste-
oblasts as previously described (Izu et al. 2011a, 2011b).
Briefly, primary osteoblasts cultured in non-osteogenic medi-
um were seeded on 18-mm cover slips at 2 × 104 cells/well in
a 12-well plate and further cultured in either non-osteogenic or
osteogenic medium. Cells were then fixed with 4 % parafor-
maldehyde on days 2, 4 (confluent), and 11 (7 days after
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confluence). The coverslips were blocked with 10 % goat
serum with or without prior permeabilization with 0.3 %
Triton X-100. Samples were then incubated with rabbit poly-
clonal anti-collagen VI (1:500; Cosmo Bio, Tokyo, Japan),
rabbit polyclonal anti-collagen XII (1:250; Izu et al. 2011b),
guinea pig polyclonal anti-collagen XII (1:250; Izu et al.
2011b), and/or rabbit polyclonal anti-collagen I (1:500, Life
Technologies) at 4 °C overnight. Secondary antibodies (goat
anti-rabbit IgG Alexa 488 or goat anti-guinea pig IgG Alexa
546) were used at a 1:500 dilution. As a negative control, cells
were incubated with secondary antibodies only. In addition,
cells were labeled with vibrant DiI (1,1′-dioctadecyl 3,3,3′,3′-
tetramethylindocarbocyanine perchlorate; 1:200; Thermo
Fisher Scientific, Mass., USA), stained with Alexa-488-
Fig. 1 Collagen VI localization
in primary osteoblasts cultured in
non-osteogenic medium.
Immunofluorescence analysis of
collagen VI was performed in
primary osteoblasts under non-
osteogenic conditions. The cells
were harvested on days 2 (a-c), 4
(d-f), and 11 (g-i) and
immunostained for collagen VI
(red) with permeabilization by
Triton X-100. Phalloidin (green)
and DAPI (blue) were used to
detect cell shape and nuclei,
respectively. As shown in the
merged images, collagen VI
immunoreactivity was observed
intra- and extracellularly.
Extracellular collagen VI was
localized between adjacent
osteoblasts (arrows) on day 2 (a,
b). This extracellular localization
was gradually increased on days 4
(d, e) and 11 (g, h). Bars 50 μm.
On day 4, osteoblasts were
stained for collagen VI (green)
without permeabilization and then
captured by confocal microscopy
(j-n). DiI (red) and DAPI (blue)
were used to detect cell shape and
nuclei, respectively (2ab
secondary antibody only as a
control (n)). As shown in the high
magnification image in the inset
from the merged image (j’),
extracellular collagen VI
connected cell bodies without the
presence of protrusions.
Bars 25 μm
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labeled phalloidin (1:200; Life Technologies), or imaged as
phase contrast to visualize cell shapes. Prolong Gold DAPI (4,
6-diamidino-2-phenylindole) mounting medium (Life
Technologies) was used for nuclear localization. Images were
captured by using a confocal laser-scanning microscope
(Fluo-View FV10i; Olympus, Tokyo, Japan) or a fluorescence
microscope (Olympus BX51; Olympus).
Western blot analysis
Primary osteoblasts cultured for 2, 4, or 11 days were used for
western blot analysis. Medium was changed to non-
osteogenic or osteogenic medium without FBS 1 day before
harvesting. Media and cells, which were lysed in lysis buffer
containing 50 mM TRIS–HCl, 1 M NaCl, 10 mM EDTA, and
Fig. 2 Collagen VI localization
in matrix bridges connecting
adjacent cells in osteogenic
medium. Immunofluorescence
analysis of collagen VI was
performed in primary osteoblasts
in osteogenic medium. The cells
were harvested on days 2 (a-c), 4
(d-f), and 11 (g-i) and
immunostained for collagen VI
(red) with permeabilization by
Triton X-100. Phalloidin (green)
and DAPI (blue) were used to
detect cell shape and nuclei,
respectively. As shown in the
merged image, collagen VI
immunoreactivity was observed
intra- and extracellularly.
Extracellular collagen VI was
localized between adjacent
osteoblasts (arrows) on day 2 (a,
b). This extracellular localization
was gradually increased on days 4
(d, e) and 11 (g, h). Osteogenic
medium increased collagen VI
expression when compared to
non-osteogenic medium.
Bars 50 μm. On day 4,
osteoblasts were stained for
collagen XII (green) without
permeabilization and then
captured by confocal microscopy
(j-n). The merged image
demonstrates that extracellular
collagen VI is localized between
adjacent cells (2ab secondary
antibody only as a control (n)).
The high magnification image in
the inset from the merged image
reveals that extracellular collagen
VI connects cell bodies without
the presence of protrusions (j’).
Bars 25 μm
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0.1 % SDS, were used for SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE) and western blotting. SDS-PAGE was
performed with 4–15 % acrylamide gel under denaturing condi-
tions. Western blotting was performed as previously described
(Izu et al. 2009) by using rabbit polyclonal anti-collagen VI
(1:1000; Novus Biologicals, Littleton, Colo., USA), rabbit
polyclonal anti-collagen XII (1:1000; Izu et al. 2011b), rabbit
polyclonal anti-collagen I (1:3000; Life Technologies), and
mouse anti-β-actin (1:4000; Sigma, St Louis, Mo., USA) prima-
ry antibodies and anti-mouse or anti-rabbit horseradish peroxi-
dase (HRP)-conjugated secondary antibodies (Jackson
ImmunoResearch, Westgrove, Pa., USA).
Fig. 3 Collagen XII is not
localized extracellularly in non-
osteogenic medium.
Immunofluorescence analysis of
collagen XII was performed in
primary osteoblasts in non-
osteogenic medium. The cells
were harvested on days 2 (a-c), 4
(d-f), and 11 (g-i) and
immunostained for collagen XII
(red) with permeabilization.
Phalloidin (green) and DAPI
(blue) were used to detect cell
shape and nuclei, respectively.
Immunoreactivity for collagen
XII was observed intracellularly
but not extracellularly at all the
stages. Bars 50 μm. On day 4,
osteoblasts were stained for
collagen XII (green) without
permeabilization and then
captured by confocal microscopy
(j-n). DiI (red) and DAPI (blue)
were used to detect cell shape and
nuclei, respectively (2ab
secondary antibody only as a
control). As shown in the merged
image, no immunoreactivity was
detected for collagen XII. The
high magnification image in the
inset from the merged image
reveals no collagen XII
immunoreactivity between
adjacent cells connected by cell
protrusions, as shown by DiI
staining (j’). Bars 25 μm
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Quantitative analysis of cells connected via collagen
bridges
The numbers of cells connected through collagens were ana-
lyzed. Ten digital images (magnification: 20×) were randomly
selected from cells immunostained for collagens I, VI, or XII
with DiI labeling on days 2 and 4. The total number of cells
was counted by using DiI labeling to exclude cells lacking a
part of the cell body. Among the total cells, cells which had
collagen bridges were counted. The cell count was performed
in triplicate from each immunostaining group and is given as
the mean of triplicate determinants. Statistical analysis was
performed by using Student’s t-test.
Results
Collagen VI links adjacent primary osteoblasts
To analyze collagen VI localization during osteogenesis, col-
lagen VI immunofluorescence was performed with perme-
abilization by using primary osteoblasts obtained from neona-
tal mouse calvaria. Osteoblasts were cultured in non-osteo-
genic medium (Fig. 1) or osteogenic medium (Fig. 2)
and were harvested on days 2, 4, and 11. In non-
osteogenic medium, collagen VI was localized mainly
in the cytoplasm, with some extracellular extensions di-
rected toward adjacent cells on day 2 (Fig. 1a-c). The
extracellular localization of collagen VI between adja-
cent osteoblasts was detected as matrix bridges, and
the number of matrix bridges was increased on day 4
(Fig. 1d-f). On day 11, extracellular localization of col-
lagen VI was increased throughout the culture thereby
masking the collagen VI bridge structure (Fig. 1g-i).
To determine whether collagen VI bridges were lo-
calized in the intra- or extracellular milieu, cell shape
was visualized by using DiI (a lipophilic membrane
stain) and immunostaining of collagen VI without per-
meabilization, allowing visualization of extracellular col-
lagen VI only. Cells from 4-day cultures in non-
osteogenic medium were analyzed using confocal mi-
croscopy (Fig. 1j-n), revealing fine structures containing
collagen VI. These structures formed adjacent to the cell
surface and extended toward adjacent cells, resulting in
the formation of matrix bridges.
Similar to our observations in non-osteogenic medium, os-
teogenic medium induced collagen VI matrix bridge forma-
tion and intracellular localization (Fig. 2a-i). Extracellular col-
lagen VI was increased in osteogenic medium, compared with
that in non-osteogenic medium at all stages analyzed. On days
2 and 4, when cells begin to form communicating cell net-
works, extracellular collagen VI was found to be expressed as
matrix bridges, connecting adjacent cells (Fig. 2a-f). On day
11, extracellular collagen VI was visualized as well-organized
microfiber networks surrounding individual cells (Fig. 2g-i).
The extracellular localization of collagen VI in primary oste-
oblasts on day 4 in osteogenic medium was analyzed by con-
focal microscopy without permeabilization (Fig. 2j-n).
Extracellular collagen VI microfibers accumulated and be-
came thicker in matrix bridges (Fig. 2j). Therefore, collagen
VI may play a role in cell-cell interactions by accumulating in
matrix bridges between adjacent cells beginning at early
stages of osteogenesis.
Extracellular collagen XII bridges adjacent cells
in primary osteoblasts during osteogenesis
To elucidate collagen XII localization during osteogenesis,
collagen XII immunostaining with permeabilization was
carried out in primary osteoblasts cultured under non-
osteogenic (Fig. 3) or osteogenic (Fig. 4) conditions.
Collagen XII localization was restricted to the cytoplasm
in non-osteogenic medium (Fig. 3a-i). This was confirmed
by the lack of extracellular collagen XII when the cells
were immunostained without permeabilization (Fig. 3j-n).
In contrast, collagen XII was detected in the intra- and
extracellular milieu when cells were cultured in osteogenic
medium (Fig. 4a-n). Extracellular localization of collagen
XII was detected in matrix bridges on days 2 and 4 in
osteogenic medium (Fig. 4a-f). By day 11, collagen XII
was detected as an extracellular microfiber network
(Fig. 4g-i). Detailed analysis of extracellular collagen XII
localization on day 4 was performed in osteoblasts
Fig. 4 Extracellular collagen XII, but not collagen I, forms matrix
bridges under osteogenic conditions. Immunofluorescence analysis of
collagen XII (a-n) and collagen I (o-s) in primary osteoblasts cultured
in osteogenic medium. The cells were harvested on days 2 (a-c), 4 (d-f),
and 11 (g-i) and immunostained for collagen XII (red) with
permeabilization. Phalloidin (green) and DAPI (blue) were used to
detect cell shape and nuclei, respectively. Both intra- and extracellular
immunoreactivity for collagen XII was detected. Extracellular collagen
XII was localized between adjacent cells (arrows) on days 2 (a, b) and 4
(d, e). On day 11, collagen XII was detected as extracellular microfibril
networks surrounding individual cells (g, h). Bars 50 μm. Confocal
analysis reveals collagen XII (green) immunofluorescence without
permeabilization in osteoblasts on day 4 (j-n). DiI (red) and DAPI
(blue) were used to detect cell shape and nuclei, respectively (2ab
secondary antibody only as a control). Extracellular microfibers of
collagen XII were localized between adjacent cells and connected each
cell (j). As seen in the high magnification image in the inset, distinct
collagen XII matrix bridges were attached to the adjacent cell (j’). No
cell protrusions, as shown by DiI, were observed with the matrix bridges.
Bars 25 μm. Confocal images of collagen I (green) in primary osteoblasts
cultured in osteogenic medium for 4 days, staining without permeabilization
(o-s). DiI (red) and DAPI (blue) were used to detect cell shape and nuclei,
respectively (2ab secondary antibody only as a control). Extracellular
collagen I was localized pericellularly (p). As shown in the high
magnification image in the inset, extracellular collagen I was localized on
the cell surface, and no matrix bridges were detected (o’). Bars 25 μm
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cultured under osteogenic condition without perme-
abilization using confocal microscopy (Fig. 4j-n). The data
demonstrate that extracellular collagen XII indeed forms
matrix bridges connecting adjacent osteoblasts.
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To elucidate whether collagen matrix bridges were specific
for collagens VI and XII, we next investigated the localization
of collagen I by confocal microscopy in primary osteoblasts
cultured in osteogenic medium (Fig. 4o-s). In contrast to the
observed localization of collagens VI and XII, extracellular
collagen I was localized pericellularly, suggesting that colla-
gen I does not form matrix bridges under conditions in which
matrix bridges were formed by collagens VI and XII.
Collagens VI and XII colocalize during formation
of communicating cell networks under osteogenic
conditions
To investigate whether collagens VI and XII were colocalized
in matrix bridges, double immunostaining for collagens VI
and XII was performed in primary osteoblasts under non-
osteogenic (Supplementary Fig. 1a) or osteogenic (Fig. 5a-g,
Supplementary Fig. 1b) conditions. Under non-osteogenic
conditions, only collagen VI was detected in the extracellular
milieu, as expected (Supplementary Fig. 1a). In contrast, al-
though collagen VI immunoreactivity exhibited a broader lo-
calization than that of collagen XII (Supplementary Fig. 1),
both collagens were localized in matrix bridges, where they
were partially colocalized on days 2 and 4. Confocal images
with phase contrast clearly demonstrated the presence of ex-
tracellular collagens VI and XII in matrix bridges, with partial
colocalization observed on day 4 (Fig. 5a-g). These observa-
tions indicate that collagens VI and XII coordinately regulate
the formation of communicating cell networks during
osteogenesis.
Collagens I and XII do not interact during matrix bridge
formation
Collagens I and XII are thought to interact during
fibrillogenesis (Font et al. 1996; Keene et al. 1991; Koch
et al. 1995; Nishiyama et al. 1994). Therefore, we next ana-
lyzed the localization of collagens I and XII during matrix
bridge formation under non-osteogenic (Supplementary
Fig. 2a) or osteogenic (Fig. 5h-n, Supplementary Fig. 2b) con-
ditions. As expected, no extracellular localization of collagens
I and XII was detected under non-osteogenic conditions
(Supplementary Fig. 2a). Although collagens I and XII were
colocalized close to the cell surface on days 2 and 4 in osteo-
genic medium, no colocalization in matrix bridges was detect-
ed. On day 11, no clear matrix bridge formation was detected
because collagens I and XII were both observed in the extra-
cellular milieu forming microfiber networks. A detailed analy-
sis by confocal microscopy in primary osteoblasts revealed that
collagens I and XII were colocalized pericellularly but not in
matrix bridges in which only collagen XII immunoreactivity
was observed (Fig. 5h). These data suggest that collagens I
and XII do not interact during matrix bridge formation.
To support these findings further, western blot analysis was
performed in primary osteoblasts cultured in non-osteogenic or
osteogenic medium (Supplementary Fig. 3). Consistent with
the immunostaining data, collagens VI, XII, and I were
expressed in cells cultured under both non-osteogenic and os-
teogenic conditions. Collagen VI expression in culture medium
was similar between non-osteogenic and osteogenic conditions,
whereas collagen XII expression in culture medium was only
observed under osteogenic conditions, suggesting that the ex-
tracellular localization of collagenXII only occurred when cells
were cultured in osteogenic medium. Similar to collagen XII,
the secreted form of collagen I, which was visualized as the
lower band, was only detected in osteogenic medium.
Cells are bridged via collagens VI and XII,
but not collagen I
We next quantified matrix bridge formation by counting cells
harboring collagen bridges (Fig. 5o). Cells were counted
based on the immunofluorescence images of cells cultured
under osteogenic conditions. The percentages of the cells with
collagen VI bridges on days 2 and 4 were 39 % and 75 %,
respectively. Collagen XII bridges were observed in 21 % of
cells on day 2 and 51 % of cells on day 4. By contrast, the
percentages of cells harboring collagen I on days 2 and 4 were
8 % and 17 %, respectively. We also analyzed the percentage
Fig. 5 Matrix bridge formation is specific for collagens VI and XII, but
not collagen I under osteogenic conditions. Confocal images of double
immunostaining for collagens VI and XII (a-g) and collagens I and XII
(h-n) in primary osteoblasts cultured for 4 days under osteogenic
conditions without permeabilization. DAPI (blue) and phase contrast
(gray) were used to detect nuclear localization and cell shape,
respectively. Osteoblasts stained with secondary antibodies and DAPI
were used as a negative control (2ab + DAPI). The merged image
demonstrates the localization of collagens VI (green) and XII (red) in a
matrix bridge between adjacent cells (arrows in a-e). The high
magnification image in the inset demonstrates partial colocalization of
collagens VI and XII (a’). As shown in the merged image,
colocalization of collagens I (green) and XII (red) was detected
pericellularly (asterisks in h-l). The high magnification image in the
inset demonstrates collagen XII localization between adjacent cells but
not collagen I (h’). Bars 25 μm. The number of cells connected via
collagens VI, XII, and I was analyzed in immunofluorescence images
after cells had been cultured in osteogenic medium for 2 and 4 days (o).
The mean percentages of cells which had collagen bridges were
calculated based on the total number of cells observed in each image.
Ten digital images were used from cells immunostained for collagens I,
VI, XII, or VI and XII. Measurements were performed in triplicate. The
number of cells with collagen VI or XII bridges was higher than that with
collagen I bridges on day 2. In addition, the percentage of cells which had
both collagens VI and XII was significantly higher than that which had
collagen I bridges. The number of cells with collagen VI, collagen XII, or
both collagens VI and XII was increased, whereas that of cells with
collagen I did not change on day 4. Statistical analysis revealed that the
number of cells with collagen VI and/or collagen XII matrix bridges was
significantly higher than that with collagen I on days 2 (*P< 0.06) and 4
(**P< 0.005)
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of cells which had bridges positive for both collagens VI and
XII. On days 2 and 4, the percentages were 35 % and 53 %,
respectively, similar to the data obtained for the separate
analyses of collagens VI or XII. Statistical analysis revealed
that the percentages of cells with collagens VI and XII were
significantly higher than those with collagen I. Therefore, the
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matrix bridges formed in adjacent osteoblasts consist of
collagens VI and XII.
Complex containing collagens VI and XII is required
for matrix bridge formation during osteogenesis
To elucidate the possible functional relationship between col-
lagens VI and XII, we next investigated whether deficiencies
in collagen VI or XII affect matrix bridge formation during
osteogenesis. Immunostaining for collagen VI or XII was per-
formed in the primary osteoblasts obtained from wild-type,
Col6a1 −/−, and Col12a1 −/− mice after culture under osteo-
genic conditions (Fig. 6a-l). Matrix bridge formation was ab-
sent or decreased in Col6a1 −/− or Col12a1 −/− osteoblasts
(Fig. 6a-l). Quantification of cells which had matrix bridges
revealed that matrix bridge formation was significantly de-
creased in primary osteoblasts from Col6a1 −/− or Col12a1
−/− mice compared with that from wild-type mice (Fig. 6m,
n). These data strongly indicate that collagens VI and XII form
a complex during matrix bridge formation, and that this com-
plex is required in order to establish communicating cell net-
works during bone formation.
Discussion
During bone formation, establishment of well-organized
communicating cell networks is essential for appropriate os-
teoblast maturation and subsequent bone matrix secretion,
which collectively define bone volume and quality. Here, we
demonstrate, for the first time, the existence of a novel coor-
dinated regulatory mechanism involving collagens VI and
XII. This regulates the formation of communicating osteoblast
networks that control/promote bone formation. Matrix bridge
formation is specific for collagens VI and XII, and the regu-
lation of this process requires the presence of both collagens.
Our data indicate that the interaction between collagens VI
and XII regulates cell-cell interactions at bone-forming sites
during bone formation.
At bone-forming sites, well-arranged osteoblasts interact
through gap junctions, tight junctions, and the receptor-
ligand system. Impaired cell-cell interactions result in defects
in bone mass (Chaible et al. 2011; Lecanda et al. 2000;
Watkins et al. 2011); therefore, cell-cell interactions are essen-
tial for the formation of healthy, strong bones. Our present
data indicate that collagens VI and XII colocalize, and that
this colocalization is restricted to matrix bridges between ad-
jacent osteoblasts during the establishment of communicating
cell networks. Interestingly, we also found that collagens XII
and I colocalize; however, the localization pattern of these
collagens is distinct from that observed for collagens VI and
XII. Thus, the function of the collagen VI and XII complex is
as a specific regulator, facilitating communicating cell
network formation that is required at the beginning of bone
formation.
In addition to the colocalization of collagens VI and XII, we
also demonstrate that deficiencies in collagen VI or XII impair
matrix bridge formation, suggesting that matrix bridge forma-
tion requires both collagens VI and XII. This is the first evi-
dence demonstrating a functional interaction between collagens
VI and XII. In support of the current data, our previous reports
demonstrate that deficiencies in collagen VI (Izu et al. 2012)
and collagen XII (Izu et al. 2011b) result in a disorganized
osteoblast arrangement at bone-forming sites and therefore
cause decreased bone mass and fragility. We have also demon-
strated that collagen XII regulates cell-cell communications via
gap junctions in osteoblasts. These observations strongly indi-
cate that the collagen VI/XII complex regulates the sequence of
events necessary for the formation of communicating cell net-
works. Therefore, these interactions are critical in establishing
well-organized osteoblasts at bone-forming sites.
The structure of collagen matrix bridges, as determined in
this study, might be similar to that of cell protrusions or cell
bridges (Zhang and Zhang 2013). Our immunolocalization
analysis has occasionally demonstrated collagen VI and XII
localization on the tips of cell protrusions. However, most col-
lagen VI and XII bridges seem to connect cell bodies rather
than cell protrusions. In addition, immunostaining without the
use of permeabilization together with DiI labeling or phase
contrast images has revealed the distinct extracellular localiza-
tion of collagens VI and XII. In the typical process of fibril
formation with collagen I, procollagens are released into the
extracellular environment through secretory vacuoles known
as Golgi-to-plasma membrane carriers (GPCs). Although the
details of the GPC secretion pathway are still under investiga-
tion, fibril formation is known to occur in compartments asso-
ciated with both cell protrusions and cell bodies, and no clear
evidence has demonstrated that protrusion formation is re-
quired for collagen secretion (Banos et al. 2008; Birk and
Trelstad. 1986; Kalson et al. 2015). Further studies should in-
vestigate the mechanisms involved in matrix bridge formation.
Fig. 6 Collagen VI or XII deficiency disrupts matrix bridge formation.
Primary osteoblasts obtained from wild-type (WT), Col6a1−/−, or
Col12a1−/− mice were cultured in osteogenic medium for 4 days and
were then immunostained for collagen VI (a-f) and XII (g-l) with DiI
(red) and DAPI (blue). Collagen VI (green) bridge formation (arrows)
between adjacent cells was detected in osteoblasts from WT mice (a, b).
In contrast, most collagen VI was accumulated on the cell surface, and a
few fine bridges (double arrows) were detected inCol12a1−/− osteoblasts
(e, f). Similar to collagen VI staining in Col12a1−/− osteoblasts, collagen
XII (green) expression was limited in Col6a1−/− osteoblasts (asterisks in
i, j). Note the collagen XII matrix bridge (arrow) g, h. Bars 50 μm
Quantification of collagen bridges (m, n). The percentage of cells
harboring collagen bridges was calculated based on immunostaining on
day 4. Collagen VI bridge formation was significantly decreased in
Col12a1−/− osteoblasts compared with WT osteoblasts (m). Similarly,
collagen XII bridge formation was significantly decreased in Col6a1−/−
osteoblasts (n). *P< 0.02
632 Cell Tissue Res (2016) 364:623–635
Cell Tissue Res (2016) 364:623–635 633
In this study, we have found that collagen VI deficiency
decreases collagen XII deposition in our culture system and
vice versa. These data are inconsistent with a previous report
in which no abnormalities in collagen VI immunoreactivity
have been observed in fibroblasts obtained from patients with
COL12A1 mutations (Hicks et al. 2014), and the same is true
for the COL6mutation cases. This can be explained by differ-
ences in the culture period, because we analyzed the cells as
cell-cell connections are beginning to form, whereas skin fi-
broblasts in the previous study were analyzed at confluence
(Hicks et al. 2014). Alternatively, this difference might be
explained by differences in cell type (Jimenez-Mallebrera
et al. 2006). Although the data are different to some degree,
both studies support the idea that a deficiency in at least one
type of collagen is sufficient to cause BM and UCMD.
Therefore, the coordinated role(s) of collagens VI and XII in
a single mechanism are indispensable for the function of the
complex, and each collagen cannot compensate for the dys-
function of the other.
The comparison between non-osteogenic and osteogenic
medium has revealed that the extracellular localization of col-
lagen VI is independent of the osteogenic medium, whereas
the extracellular collagens I and XII are restricted under oste-
ogenic conditions. This is consistent with our western blot
analysis of culture medium, suggesting that collagen VI is
secreted prior to collagen I and XII by osteoblasts during very
early stages. However, collagen VI assembly might not be
sensitive to ascorbate, which is generally required for collagen
triple helix formation, since no ascorbate was supplemented in
the non-osteogenic medium. In contrast, triple helixes of col-
lagens I and XII might not be stable and could be retained
intracellularly without ascorbate (Franceschi and Iyer 1992).
Alternatively, the secretion of collagens I and XII might be
closely associated. Collagen XII belongs to the FACIT sub-
family and is associated with collagen I fibril assembly. In
addition, our data have demonstrated the pericellular
colocalization of collagens I and XII during osteogenesis.
Many studies have shown that Col1a1 mRNA is not
expressed during very early stages of osteogenesis but is pres-
ent during the middle phases of osteoblast differentiation un-
der osteogenic conditions (Askmyr et al. 2009; Hu et al.
2005), suggesting that the extracellular secretion of collagen
XII is dependent on collagen I secretion. Therefore, collagen
VI might be secreted earlier than collagen XII, and these two
collagens might function together when collagen XII is secret-
ed by osteoblasts during bone formation.
Although mutations in collagens VI or XII cause BM and
UCMD, the functional contributions of collagen VI and XII in
these diseases are still controversial (Allamand et al. 2011;
Bernardi and Bonaldo. 2008; Grumati et al. 2010; Hicks
et al. 2014; Lamande et al. 2002; Zou et al. 2014).
Dysfunction ofmitochondria and impaired clearance by autoph-
agy has been shown to induce spontaneous apoptosis, leading to
the development of BM and UCMD (Bonaldo et al. 1998;
Grumati et al. 2010; Irwin et al. 2003). Because the disruption
of cell-cell connections induces apoptosis (Kalvelyte et al.
2003; Wilson et al. 2000), our data indicate that the impaired
formation of communicating cell networks between myocytes
and muscular fibroblasts and tenocytes, skin fibroblasts, and
osteoblasts might be the key to developing BM and UCMD.
In conclusion, we demonstrate, for the first time, that a
functional interaction occurs between collagens VI and XII
in primary osteoblasts during osteogenesis. Although colla-
gens VI and XII are different subtypes of collagen, both col-
lagens are indispensable for function in establishing commu-
nicating cell networks at bone-forming sites, as required for
appropriate bone formation.
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